Skip to content
‹ Back to IndustriesHealthcare

Cost Containment Strategies for Healthcare Plans

The rising costs of prescription medications in the U.S. are top of mind for anyone who relies on daily doses for their health. Between 2000 and 2017, some studies put the prescription drug cost increases in the U.S. as high as 76%. So, what are consumers to do? Greg Santulli, CEO of RX Valet, offered…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Healthwallet on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The rising costs of prescription medications in the U.S. are top of mind for anyone who relies on daily doses for their health. Between 2000 and 2017, some studies put the prescription drug cost increases in the U.S. as high as 76%. So, what are consumers to do?

Greg Santulli, CEO of RX Valet, offered an alternative for those looking to lower their overall prescription medication costs, and he spoke with host Shelby Skrhak about RX Valet’s solution.

“RX Valet was founded five years ago, really on the principle of bringing better value to consumers and members of RX Valet,” Santulli said. “RX Valet is offered primarily through memberships through various vehicles either as a benefit as part of your health plan or as some other type of health offering.”

The fundamental tenant of RX Valet is to give access to medications at a reasonable price.

Santulli recognized and affirmed that drug prices had reached an untenable situation in the U.S. If someone doesn’t have the correct type of healthcare coverage, many of the medications one sees advertised on television are unobtainable.

“Or they were unobtainable until you go to our site and be part of the RX Valet family,” Santulli said. “What we do is we find ways to get you the medications that you need at reasonable prices.”

RX Valet provides the engine that searches for those savings and gives customers options to gain people access to lower-cost medications. If receiving prescriptions by mail is an option for someone, the savings can add up, but RX Valet provides savings at a participant’s pharmacy, too. Santulli said RX Valet would connect the dots to get people the medications they need, generic or brand-name, at an affordable price, in the method that works best for them.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthwallet

Part of this channel

Healthwallet

Employer healthcare cost containment with concierge-level benefits navigation.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Ambulatory surgery center volumes are projected to rise 24% over the next decade. Shortages in anesthesiology and gastroenterology are projected for 2027. That puts the staffing gap early in the growth period, so for operators planning coverage and outpatient capacity, the nearer 2027 date sets the pace.

  • 01A 24% ten-year forecast and a 9% forecast for 2023 to 2028 measure different windows; check the time frame and start year before putting either in a budget.
  • 02With about nine in ten ASCs at least partly physician-owned, a staffing gap could hit physician owners directly as clinicians and investors.

Oct 30, 2026

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Berg Insight expects 160 million home medical monitors in care programs by 2030

Berg Insight expects 160 million home medical monitors in care programs by 2030

Prescribed connected home medical monitors are forecast to grow from 92.7 million in 2025 to 159.7 million by 2030. Fastest growth is in diabetes, remote ECG and medication compliance, spread across many suppliers. Berg and IoT Business News argue value depends on integrating data into workflows.

  • 01159.7 million prescribed home medical monitors expected by 2030, growing at 11.5 percent annually from 92.7 million in 2025.
  • 02Sleep therapy is the largest connected segment, followed by diabetes with 19.5 million connections at end of 2025, with fastest future growth in diabetes, remote ECG and medication compliance monitoring.
  • 03Clinical value increasingly depends on integrating data across devices into workflows: vendors combine hardware, software, analytics and interoperability with existing healthcare systems.

Oct 26, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512